Akoya Biosciences Inc (AKYA)
1.45
-0.09
(-5.84%)
USD |
NASDAQ |
Mar 26, 16:00
1.46
+0.01
(+0.69%)
After-Hours: 20:00
Akoya Biosciences Enterprise Value: 113.38M for March 26, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quanterix Corp | -30.87M |
| Bruker Corp | 8.546B |
| Azenta Inc | 1.200B |
| Harvard Bioscience Inc | 59.78M |
| Bionano Genomics Inc | 0.5253M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.199M |
| Revenue (Quarterly) | 21.34M |
| Total Expenses (Quarterly) | 27.07M |
| EPS Diluted (Quarterly) | -0.17 |
| Gross Profit Margin (Quarterly) | 67.41% |
| Profit Margin (Quarterly) | -38.41% |
| Earnings Yield | -77.93% |
| Normalized Earnings Yield | -71.80 |